Apela/Elabela/Toddler: New perspectives in molecular mechanism of heart failure

Background. Despite significant therapeutic advances, heart failure (HF) remains unacceptably high in morbidity and mortality. Additionally, its high-care and costs make HF a deadly and costly disease. First reported independently by two group of researchers, Apela/Elabela/Toddler (ELA) is the secon...

Descripción completa

Detalles Bibliográficos
Autores principales: Sunjaya, Anthony P., Sunjaya, Angela F., Ferdinal, Frans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Magdi Yacoub Heart Foundation 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865182/
https://www.ncbi.nlm.nih.gov/pubmed/31799290
http://dx.doi.org/10.21542/gcsp.2019.15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865182/
https://www.ncbi.nlm.nih.gov/pubmed/31799290
http://dx.doi.org/10.21542/gcsp.2019.15

Ejemplares similares